Expression of human endogenous retrovirus-K is strongly associated with the basal-like breast cancer phenotype
暂无分享,去创建一个
Xiaoping Su | Feng Wang-Johanning | John N. Weinstein | J. Weinstein | F. Esteva | X. Su | G. Malouf | Xiaofeng Zheng | Francisco J. Esteva | Gabriel G. Malouf | Xiaofeng Zheng | G. Johanning | F. Wang-Johanning | Gary L. Johanning
[1] C. Hao,et al. PD-0332991 induces G1 arrest of colorectal carcinoma cells through inhibition of the cyclin-dependent kinase-6 and retinoblastoma protein axis , 2014, Oncology letters.
[2] Carmen Jerónimo,et al. P-Cadherin Overexpression Is an Indicator of Clinical Outcome in Invasive Breast Carcinomas and Is Associated with CDH3 Promoter Hypomethylation , 2005, Clinical Cancer Research.
[3] E. Meese,et al. Human Endogenous Retrovirus Family HERV-K(HML-5): Status, Evolution, and Reconstruction of an Ancient Betaretrovirus in the Human Genome , 2004, Journal of Virology.
[4] F. McCormick,et al. Oncogenic and wild-type Ras play divergent roles in the regulation of mitogen-activated protein kinase signaling. , 2013, Cancer discovery.
[5] J. Ruppert,et al. MicroRNA‐Based Therapeutic Strategies for Targeting Mutant and Wild Type RAS in Cancer , 2015, Drug development research.
[6] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumours , 2013 .
[7] J. Reis-Filho,et al. Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer , 2007, Modern Pathology.
[8] K. Hunt,et al. Chimeric antigen receptor T cells targeting HERV-K inhibit breast cancer and its metastasis through downregulation of Ras , 2015, Oncoimmunology.
[9] Zhiyuan Hu,et al. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors , 2007, Genome Biology.
[10] Anastasia Ivanova,et al. TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] M. Zvelebil,et al. Embryonic mammary signature subsets are activated in Brca1-/- and basal-like breast cancers , 2013, Breast Cancer Research.
[12] Selvaraju Veeriah,et al. Patient-derived xenografts of triple-negative breast cancer reproduce molecular features of patient tumors and respond to mTOR inhibition , 2013, Breast Cancer Research.
[13] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[14] A. Skoultchi,et al. CDK6 blocks differentiation: coupling cell proliferation to the block to differentiation in leukemic cells , 2003, Oncogene.
[15] D. Edwards,et al. Wild-Type N-Ras, Overexpressed in Basal-like Breast Cancer, Promotes Tumor Formation by Inducing IL-8 Secretion via JAK2 Activation. , 2015, Cell reports.
[16] J. Weinstein,et al. Comprehensive analysis of long non-coding RNAs in human breast cancer clinical subtypes , 2014, Oncotarget.
[17] S. Olivares,et al. Genetic Engineering of T Cells to Target HERV-K, an Ancient Retrovirus on Melanoma , 2015, Clinical Cancer Research.
[18] K. Hess,et al. Human endogenous retrovirus type K antibodies and mRNA as serum biomarkers of early‐stage breast cancer , 2014, International journal of cancer.
[19] Francis Harper,et al. Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements. , 2006, Genome research.
[20] L. Ramondetta,et al. Cytotoxicity of Human Endogenous Retrovirus K–Specific T Cells toward Autologous Ovarian Cancer Cells , 2014, Clinical Cancer Research.
[21] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumors , 2012, Nature.
[22] K. Hunt,et al. Immunotherapeutic potential of anti-human endogenous retrovirus-K envelope protein antibodies in targeting breast tumors. , 2012, Journal of the National Cancer Institute.
[23] A. Jemal,et al. Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.
[24] N. Hacohen,et al. Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity , 2015, Cell.
[25] J. Lenz,et al. A Single Amino Acid Substitution in a Segment of the CA Protein within Gag That Has Similarity to Human Immunodeficiency Virus Type 1 Blocks Infectivity of a Human Endogenous Retrovirus K Provirus in the Human Genome , 2008, Journal of Virology.
[26] S. Byers,et al. Soluble‐E‐cadherin activates HER and IAP family members in HER2+ and TNBC human breast cancers , 2014, Molecular carcinogenesis.
[27] R. Blamey,et al. E-cadherin as a prognostic indicator in primary breast cancer , 2001, British Journal of Cancer.
[28] G. Bourque,et al. The Majority of Primate-Specific Regulatory Sequences Are Derived from Transposable Elements , 2013, PLoS genetics.
[29] K. Khalili,et al. Evidence that a cell cycle regulator, E2F1, down-regulates transcriptional activity of the human immunodeficiency virus type 1 promoter , 1995, Journal of virology.
[30] Jason I. Herschkowitz,et al. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer , 2010, Breast Cancer Research.
[31] A. Ribeiro,et al. P-Cadherin Linking Breast Cancer Stem Cells and Invasion: A Promising Marker to Identify an “Intermediate/Metastable” EMT State , 2014, Front. Oncol..
[32] F. Pedersen,et al. Human endogenous retroviruses sustain complex and cooperative regulation of gene-containing loci and unannotated megabase-sized regions , 2015, Retrovirology.
[33] R. Weiss,et al. Human endogenous retroviruses: friend or foe? , 2016, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[34] T. Heidmann,et al. Identification of a Functional Envelope Protein from the HERV-K Family of Human Endogenous Retroviruses , 2005, Journal of Virology.
[35] Charles M Perou,et al. EGFR associated expression profiles vary with breast tumor subtype , 2007, BMC Genomics.
[36] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[37] J. Coffin,et al. Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retroviruses , 2011, Retrovirology.
[38] J. Montero,et al. Active kinase profiling, genetic and pharmacological data define mTOR as an important common target in triple-negative breast cancer , 2014, Oncogene.
[39] B. Law,et al. Mammary tumors initiated by constitutive Cdk2 activation contain an invasive basal-like component. , 2008, Neoplasia.
[40] J. Kidd,et al. Discovery of unfixed endogenous retrovirus insertions in diverse human populations , 2016, Proceedings of the National Academy of Sciences.
[41] J. Lees,et al. Life and death decisions by the E2F transcription factors. , 2007, Current opinion in cell biology.
[42] Minetta C. Liu,et al. Circulating Tumor Cell Analysis in Metastatic Triple-Negative Breast Cancers , 2014, Clinical Cancer Research.
[43] Gabor T. Marth,et al. MOSAIK: A Hash-Based Algorithm for Accurate Next-Generation Sequencing Short-Read Mapping , 2013, PloS one.
[44] Yongchang Wei,et al. Activation of HERV-K Env protein is essential for tumorigenesis and metastasis of breast cancer cells , 2016, Oncotarget.
[45] Wnt/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome. , 2010, The American journal of pathology.
[46] Xianxiao Zhou,et al. An Integrated Approach to Uncover Driver Genes in Breast Cancer Methylation Genomes , 2013, PloS one.
[47] X. Xu,et al. The viral oncogene Np9 acts as a critical molecular switch for co-activating β-catenin, ERK, Akt and Notch1 and promoting the growth of human leukemia stem/progenitor cells , 2013, Leukemia.
[48] K. Hunt,et al. Human endogenous retrovirus K triggers an antigen-specific immune response in breast cancer patients. , 2008, Cancer research.
[49] K. Kidd,et al. Insertional polymorphisms of full-length endogenous retroviruses in humans , 2001, Current Biology.